Sepsis (severe) - drotrecogin
Drotrecogin alpha (activated) for severe sepsis
Summary
Drotrecogin alfa (activated) is recommended for adult patients who have severe sepsis that has resulted in multiple organ failure (two or more major organs are not working properly) and are being given the most appropriate intensive care support for their condition. The use of drotrecogin al ...
Guidance documents
Implementing this guidance
Other information
About this guidance
Technology appraisals TA84
Issued: September 2004
How this guidance was produced
